Editorial & Medical Review Policy

Last reviewed: May 22, 2026

Every piece of health intelligence published under the Lucetic name is governed by this framework. It defines how we source, verify, write, review, and update content across every touchpoint of our brand.

Chief Medical Reviewer: Dr. Joseph Nightingale, MBBS MSc
Review Frequency: Quarterly minimum

1. Our Commitment to Accurate Health Information

Lucetic operates in the functional mushroom supplement space — a category that sits within the broader YMYL (Your Money or Your Life) content classification defined by Google's Quality Rater Guidelines and, more importantly, a category where accuracy directly affects the health decisions of real people. We take that responsibility seriously. This policy is not a legal disclaimer. It is the operational standard that every writer, researcher, and reviewer at Lucetic is required to follow before any piece of content is published on our platforms, including lucetic.com, our email communications, and our social media channels.

Guiding principle: We publish only what the evidence currently supports, disclosed at the appropriate confidence level. We never state more than the science warrants. We never omit limitations that a reader would reasonably want to know.

2. Editorial Team & Accountability Structure

All Lucetic content is produced and reviewed within a two-tier accountability structure: the Lucetic Editorial Board, responsible for research and writing, and the Medical Review Office, responsible for clinical accuracy.

Chief Medical Reviewer (Dr. Joseph Nightingale, MBBS MSc) — Holds final authority over all health claims, clinical interpretations, and evidence gradings. Reviews all content prior to publication and signs off on each quarterly update cycle.
Lucetic Editorial Board (Research & Content Specialists) — A team of specialist writers and researchers responsible for sourcing primary literature, drafting content, and maintaining the citation database. All members hold relevant academic qualifications in life sciences, nutrition, or science communication.
Compliance Review (Regulatory & Legal Oversight) — All content touching product efficacy or health outcomes is reviewed against current DSHEA guidelines and FDA structure-function claim regulations before publication.
Editorial Independence (Content & Commerce Separation) — The editorial team operates independently of Lucetic's sales and marketing functions. Commercial teams have no editorial approval rights. Conflicts of interest are disclosed at the article level.

Dr. Nightingale is a physician and pharmaceutical researcher with a specialization in adaptogenic botanicals, nutritional science, and evidence-based supplementation. He is responsible for ensuring all published content on Lucetic's platforms reflects the current scientific consensus and complies with applicable regulatory standards.

3. Medical Review Process

Every article, product page, sourcing document, and science page published on lucetic.com follows a mandatory four-stage review process before it is approved for publication.

Stage 1 — Primary Research. The Editorial Board identifies and reviews all relevant peer-reviewed literature. A minimum of three primary sources are required per major health claim. Source quality is graded using the Citation Hierarchy defined in Section 4.
Stage 2 — First Draft & Citation Tagging. The writer produces a first draft with inline citations linking directly to PubMed or the publisher's DOI. All claims are tagged with their evidence tier (T1, T2, or T3) before medical review begins.
Stage 3 — Medical Review. Dr. Nightingale (or a designated qualified reviewer) independently evaluates every health claim against its cited source. Unsubstantiated or overstated claims are flagged and returned for revision. No content bypasses this stage.
Stage 4 — Compliance & Publication Sign-Off. Regulatory language is verified for DSHEA compliance. The article receives a “Medically Reviewed” designation, the reviewer's name and credentials are published at the article level, and the content is cleared for publication.

All published articles display a “Medically Reviewed” stamp with the reviewer's name, credentials, and the date of most recent review. When content is updated, the review date is refreshed and the nature of the update is logged in the article's revision history.

4. Three-Tier Citation Hierarchy

Lucetic enforces a strict, tiered evidence framework. Every health claim published under our name must be traceable to a source within this hierarchy. The tier must be disclosed when the evidence is preliminary or indirect.

Tier I — Human Clinical Trials (strongest evidence, primary source required). Randomized, double-blind, placebo-controlled trials published in peer-reviewed, PubMed-indexed journals. This is the gold standard for any efficacy claim made about a Lucetic formulation. Systematic reviews and meta-analyses of qualifying trials are also included in this tier.
Tier II — Preclinical & Mechanistic Studies (preliminary, must be disclosed as such). In vitro (cell culture) and in vivo (animal model) studies that demonstrate biological mechanisms of action. Tier II evidence may be cited to explain how a compound works at a molecular level, but it must be clearly disclosed as preliminary laboratory data and must not be used to make direct efficacy claims for human outcomes.
Tier III — Historical & Ethnobotanical Records (context only, not evidence for efficacy claims). Documented traditional use of functional mushrooms across clinical traditions (Traditional Chinese Medicine, Ayurveda, etc.). Tier III sources provide historical and cultural context only. They may not be used to substantiate modern health claims and must be explicitly framed as traditional use rather than clinical evidence.

5. FDA & DSHEA Compliance Mandate

Lucetic's products are classified as dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Our editorial policy enforces strict compliance with the boundaries this legislation defines.

No Lucetic content — including blog posts, product pages, emails, or social media — may claim that any product diagnoses, treats, cures, or prevents any disease or medical condition.
Permissible structure-function claims (e.g. “supports cognitive function,” “may contribute to healthy immune response”) must be truthful, substantiated by Tier I or Tier II evidence, and accompanied by the required FDA disclaimer on all applicable pages.
All content is reviewed for implied disease claims. Language that implies a therapeutic effect — even without explicit disease naming — is treated as a prohibited claim and is revised or removed before publication.
Customer testimonials published on our platforms are reviewed for compliance. Testimonials that contain disease claims are not published, regardless of their authenticity.

DSHEA 1994 Compliant · FDA disclaimer required on all product pages · No disease treatment claims.

6. Sourcing & Lab Transparency Clause

Lucetic operates under a brand-owned contract manufacturing model. All products are formulated to Lucetic's specifications and tested by independent, ISO 17025:2017-accredited third-party laboratories before reaching the consumer. This clause governs how that data is handled in our content.

Certificates of Analysis (COAs) issued by Twin Arbor Labs are published in full and made publicly accessible via the batch verification system at lucetic.com/lab-results. No batch is withheld from the public record.
Third-party laboratory findings may not be altered, selectively presented, or filtered for marketing leverage. All results — including any findings that fall below internal targets — are disclosed, and affected batches are not shipped until they meet specification.
Product-related content (potency claims, purity claims, sourcing claims) must align with the most recent COA data on file. If laboratory findings change for a given formulation, relevant content is updated within 30 days.
Lucetic's manufacturing model is always described as brand-owned contract manufacturing. The term “white-label” is never used, as it does not accurately reflect our specification-to-production ownership model.

7. No AI-Generated Content Policy

100% of health intelligence published on Lucetic's platforms is researched, structured, written, and reviewed by qualified human specialists. We do not publish content that is generated, drafted, or synthesized by large language models (LLMs) or other AI writing tools.

Why this matters: AI-generated health content cannot independently verify its sources, assess the quality of clinical evidence, or apply regulatory judgment to supplement claims. In the supplement space, where accuracy directly impacts consumer health decisions, this limitation is not acceptable. Our readers deserve content produced by people who can be held accountable for what they write.

All articles, guides, and product descriptions are written by named human authors with verifiable credentials in their subject area.
AI tools may be used for operational tasks (scheduling, formatting, grammar checking) but may not generate, substantially rewrite, or produce health claims or clinical interpretations in any form.
Any content submitted to the editorial process that is found to be AI-generated is rejected and returned to the author for full human rewrite before resubmission.

8. Corrections & Update Policy

Scientific understanding evolves. When new evidence materially changes the accuracy of published content, or when errors are identified, we act promptly and transparently.

Minor corrections (typographical errors, broken links, formatting issues) are corrected silently within 48 hours of identification.
Substantive corrections (factual inaccuracies, outdated clinical data, retracted citations) are corrected with an editor's note appended to the article, disclosing the nature and date of the correction.
Full reviews are conducted on a quarterly cycle for all evergreen content. Articles that cannot be brought into alignment with current evidence are unpublished until they can be revised.
Readers who identify inaccuracies are encouraged to contact our editorial team at contact@lucetic.com. All submissions are reviewed within 5 business days.

9. Advertiser & Commercial Independence

Lucetic's editorial content is not influenced by commercial relationships. This principle is absolute and non-negotiable.

No third party, affiliate, or commercial partner may pay to have content published, modified, or positively framed on Lucetic's platforms.
Lucetic's own products are evaluated against the same evidence standards applied to all health claims on this site. We do not publish claims about our products that exceed what our Tier I or Tier II citation base supports.
Affiliate relationships, where they exist, are disclosed clearly at the top of any article in which they are relevant. Disclosure is not relegated to footnotes.
The editorial team's compensation is not tied to commercial performance metrics, page views, or product sales figures.

10. Policy Update Log

This page is reviewed and updated on a quarterly basis. All material changes to this policy are logged below.

May 22, 2026 — Initial Publication. Full editorial policy published. Includes Three-Tier Citation Hierarchy, DSHEA Compliance Mandate, Lab Transparency Clause, No AI-Generated Content Policy, and Corrections framework.

11. Contact Editorial

Questions about our editorial standards, corrections, or a specific claim? Contact our editorial team at contact@lucetic.com. All submissions are reviewed within 5 business days.